JPS5927359B2 - Production method of cytidine derivatives - Google Patents
Production method of cytidine derivativesInfo
- Publication number
- JPS5927359B2 JPS5927359B2 JP50102269A JP10226975A JPS5927359B2 JP S5927359 B2 JPS5927359 B2 JP S5927359B2 JP 50102269 A JP50102269 A JP 50102269A JP 10226975 A JP10226975 A JP 10226975A JP S5927359 B2 JPS5927359 B2 JP S5927359B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cytidine
- arabinofuranosyl
- cytosine
- boron trifluoride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
本発明はO2、2′−アンヒドロー1−(3’、5’−
ジーO−アシルーβ−D−アラビノフラノシル)シトシ
ン塩類の新規製法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention provides O2,2'-anhydro-1-(3',5'-
The present invention relates to a new method for producing di-O-acyl-β-D-arabinofuranosyl)cytosine salts.
上記本発明の目的化合物はいずれも抗白血病剤、。All of the above target compounds of the present invention are antileukemia agents.
抗腫瘍剤として有用な医薬化合物である。従来、O2、
2’−アンヒドロー1−(3′、5′−ジーO−アシル
ーβ−D−アラビノフラノシル)シトシン塩類の合成法
としては、例えばに)シチジンに脂肪酸ハロゲニドを反
応させる方法〔ケミカル・アンド・フアーマシユーテイ
カル・ブエレチン、22巻、128頁(1974年)〕
、回O2、2’−アンヒドロ(β−D−アラビノフラノ
シル)シトシンに無水酢酸と臭素とを反応させて得られ
るO2、2’−アンヒドロー1−(3′|5′ −ジー
O−アセチルーβ−D−アラビノフラノシル)一5−ブ
ロモシトシンを接触還元する方法〔ジャーナル・オブ・
メデイチナル・ケミストリー、15巻、1218頁(1
972年)〕、←うシチジンとα−アシルオキシアシル
ハライドとを反応させて得られるO2、2′−アンヒド
ロー1−(3′ −0−アシル−β−D−アラビノフラ
ノシル)シトシンをアシルハライドで更にアシル化する
方法(特開昭49−132084号)等が知られている
。It is a pharmaceutical compound useful as an antitumor agent. Conventionally, O2,
A method for synthesizing 2'-anhydro-1-(3',5'-di-O-acyl-β-D-arabinofuranosyl)cytosine salts is, for example, a method in which cytidine is reacted with a fatty acid halide [Chemical & Pharmaceutical Journal, Volume 22, Page 128 (1974)]
, O2, 2'-anhydro 1-(3'|5'-di-O-acetyl) obtained by reacting 2'-anhydro(β-D-arabinofuranosyl)cytosine with acetic anhydride and bromine Method for catalytic reduction of β-D-arabinofuranosyl-5-bromocytosine [Journal of
Meditinal Chemistry, Volume 15, Page 1218 (1
972)], ← O2, 2'-anhydro 1-(3'-0-acyl-β-D-arabinofuranosyl)cytosine obtained by reacting cytidine with α-acyloxyacyl halide, is converted into acyl halide. A method of further acylating with (JP-A-49-132084) is known.
しかしながらこれらの方法のうちに)の方法による場合
、シチジンから一工程で目的化合物を合成出来るものの
、低収率である。また同および(ノうの方法は原料化合
物であるO”、2’−アンヒドロー1−(β−D−アラ
ビノフラノシル)シトシンまたはその3 ′ −0−ア
シル誘導体を合成する工程を必要とし、反応操作もはん
雑であつて、上記いずれの方法も目的化合物の工業的製
造法として満足し得るものではない。上記に対して本発
明者等は種々研究を重ねた結果、シチジンと有機酸無水
物とを三フッ化ホウ素の存在下に反応させることにより
、わずか一工程反応により収率よく目的のO2、2’−
アンヒドロー1−(3′|5′ −ジーO−アシルーβ
−D−アラビノフラノシル)シトシン塩類を収率よく合
成し得ることを見出した。However, among these methods, method (2) allows synthesis of the target compound from cytidine in one step, but the yield is low. In addition, the methods of the same and (No) require a step of synthesizing the starting compound O",2'-anhydro-1-(β-D-arabinofuranosyl)cytosine or its 3'-0-acyl derivative, The reaction operations are also complicated, and none of the above methods is satisfactory as an industrial method for producing the target compound.As a result of various studies, the present inventors have found that cytidine and organic acid By reacting the anhydride with boron trifluoride in the presence of boron trifluoride, the desired O2,2'-
Anhydro 1-(3'|5'-G-O-acyl-β
It has been found that -D-arabinofuranosyl)cytosine salts can be synthesized with good yield.
本発明によれば、目的化合物のO2、2’−アンヒドロ
ー1−(3′、5′ −ジー0−アシルーβ−D−アラ
ビノフラノシル)シトシン塩類は、シチジンと有機酸無
水物とを三フッ化ホウ素の存在下に反応させることによ
り合成することが出来る。According to the present invention, the O2,2'-anhydro-1-(3',5'-di-0-acyl-β-D-arabinofuranosyl)cytosine salts of the target compound combine cytidine and an organic acid anhydride. It can be synthesized by reacting in the presence of boron fluoride.
本発明において、シチジンと有機酸無水物との反応は適
当な溶媒中三フツ化ホウ素の存在下に実施するのが好ま
しい。ここに一方の原料たる有機酸無水物としては、例
えば酢酸、プロピオン酸、ピバリン酸、ステアリン酸、
パルミチン酸、リグノセリン酸等の炭素数2乃至30個
を有する飽和脂肪族直鎖状乃至分枝状カルボン酸の酸無
水物、フエニル酢酸、フエニル酪酸等のアリール基置換
脂肪族カルボン酸の酸無水物、安息香酸、α−ナフトエ
酸、β−ナフトエ酸等の芳香族カルボン酸の酸無水物、
クロトン酸、アクリル酸、メタクリル酸、桂皮酸等のア
リール基置換もしくは非置換不飽和脂肪族カルボン酸の
酸無水物、シクロプロパンカルボン酸、シクロペンタン
カルボン酸、シクロヘキサンカルボン酸、アダマンタン
一1−カルボン酸等脂環式カルボン酸の酸無水物等を好
適例としてあげることが出来、これらはいずれもシチジ
ンと反応して相当する目的化合物に誘導される。本反応
系に存在させる三フツ化ホウ素はそれ自体もしくはそれ
とエーテル、アセトニトリル等とのコンプレツクス等が
いずれも使用出来るが、特に三フツ化ホウ素とエーテル
とのコンプレツクスが好適である。三フツ化ホウ素もし
くはそのコンプレツタスはシチジン1モルに対して概ね
1〜10モル程度、とりわけ3モル程度存在させるのが
好ましい。反応はO〜150℃、とりわけ80〜100
℃附近にて好適に進行し、反応溶媒としては例えば酢酸
、アセトニトリル、ジオキサン等が適宜使用出来る。か
くして生成した02,27−アンヒトロー1−(3′,
5′−ジ一0−アシル−β−D−アラビノフラノシル)
シトシン塩類は、例えば反応終了液より溶媒を留去して
得た残査につき、適当な溶媒による洗浄、再結晶等の公
知精製操作により容易に単離することが出来る。In the present invention, the reaction between cytidine and an organic acid anhydride is preferably carried out in the presence of boron trifluoride in a suitable solvent. Examples of the organic acid anhydride serving as one of the raw materials include acetic acid, propionic acid, pivalic acid, stearic acid,
Acid anhydrides of saturated aliphatic linear to branched carboxylic acids having 2 to 30 carbon atoms such as palmitic acid and lignoceric acid; acid anhydrides of aryl group-substituted aliphatic carboxylic acids such as phenyl acetic acid and phenyl butyric acid; , acid anhydrides of aromatic carboxylic acids such as benzoic acid, α-naphthoic acid, β-naphthoic acid,
Acid anhydrides of aryl group-substituted or unsubstituted aliphatic carboxylic acids such as crotonic acid, acrylic acid, methacrylic acid, cinnamic acid, cyclopropanecarboxylic acid, cyclopentanecarboxylic acid, cyclohexanecarboxylic acid, adamantane-1-carboxylic acid Suitable examples include acid anhydrides of isoalicyclic carboxylic acids, and any of these reacts with cytidine to yield the corresponding target compound. The boron trifluoride present in this reaction system can be used either by itself or as a complex of boron trifluoride with ether, acetonitrile, etc., and complexes of boron trifluoride and ether are particularly preferred. Boron trifluoride or its complex is preferably present in an amount of about 1 to 10 moles, particularly about 3 moles, per mole of cytidine. The reaction is carried out at 0 to 150°C, especially 80 to 100°C.
The reaction proceeds suitably at around 0.degree. C., and as the reaction solvent, for example, acetic acid, acetonitrile, dioxane, etc. can be used as appropriate. The thus generated 02,27-anhtrow 1-(3',
5'-di-10-acyl-β-D-arabinofuranosyl)
Cytosine salts can be easily isolated, for example, by using a residue obtained by distilling off the solvent from the reaction-completed solution by known purification operations such as washing with an appropriate solvent and recrystallization.
実施例 1
シチジン59をアセトニトリル150aにけん濁し、こ
れに三フツ化ホウ素・エーテルコンプレツクス7.8m
1を加える。Example 1 Cytidine 59 was suspended in acetonitrile 150a, and boron trifluoride/ether complex 7.8m was suspended in it.
Add 1.
かくはん還流下に無水酢酸6.31を含むアセトニトリ
ル50m1溶液を10分間を要して滴下する。滴下後5
分間還流し、溶媒を減圧下に留去する。得られる残査に
エーテル200dを加えて結晶化し、口取する。この結
晶をイソプロパノールで洗浄したのちエタノールより再
結晶することにより、02,2/−アンヒドロ1−(3
′,51−ジ一0−アセチル−β−Dアラビノフラノシ
ル)シトシン・HBF4塩5.79を得る。収率70%
。本品2.09を水10m1に溶解し、ダイヤイオンS
A−11B(Cド型)50m1を充填せるカラムに導通
する。While stirring and refluxing, 50 ml of acetonitrile solution containing 6.31 ml of acetic anhydride was added dropwise over 10 minutes. After dripping 5
Reflux for a minute and remove the solvent under reduced pressure. Add 200 d of ether to the resulting residue to crystallize it, and take it by mouth. By washing the crystals with isopropanol and recrystallizing them from ethanol, 02,2/-anhydro1-(3
',51-di-10-acetyl-β-D arabinofuranosyl)cytosine HBF4 salt 5.79% is obtained. Yield 70%
. Dissolve 2.09 of this product in 10ml of water, and use Diaion S.
Connect to a column filled with 50 ml of A-11B (C type).
このカラムを水100m1で洗浄したのち、通過液と洗
液を合し減圧下に濃縮することにより、02,27−ア
ンヒトロー1−(3′,5/−ジ一0−アセチル−β−
D−アラビノフラノシル)シトシン塩酸塩1.69を得
る。収率92%o実施例 2
シチジン4.09をアセトニトリル120m1にけん濁
し、三フツ化ホウ素・エーテルコンプレツクス6.2m
1を加える。After washing this column with 100 ml of water, the flow-through and washing liquid were combined and concentrated under reduced pressure to obtain
1.69% of D-arabinofuranosyl)cytosine hydrochloride is obtained. Yield 92%o Example 2 4.09 ml of cytidine was suspended in 120 ml of acetonitrile, and 6.2 ml of boron trifluoride/ether complex was suspended.
Add 1.
かくはん還流下にピバリン酸無水物9.2f1を含むア
セトニトリル40TfL1溶液を5分間を要して滴下す
る。滴下後5分間還流したのち溶媒を減圧下に留去する
。得られる残査をエーテル50m1で結晶化し、口取す
ることにより、02,2/−アンヒトロー1−(3/,
5/−ジ一0ピバロイル一β−D−アラビノフラノシル
)シトシン・HBF4塩7.09を得る。収率88%。
実施例 3シチジン1.09をアセトニトリル15m1
にけん濁し、三フツ化ホウ素・エーテルコンプレツクス
1.56m1を加える。While stirring and refluxing, a solution of 40TfL1 acetonitrile containing 9.2f1 pivalic anhydride was added dropwise over 5 minutes. After the dropwise addition, the mixture was refluxed for 5 minutes, and then the solvent was distilled off under reduced pressure. The resulting residue was crystallized with 50 ml of ether and taken by mouth to give 02,2/-Anchtrow 1-(3/,
5/-di-10pivaloyl-β-D-arabinofuranosyl)cytosine HBF4 salt 7.09 is obtained. Yield 88%.
Example 3 1.09 cytidine to 15 ml of acetonitrile
Suspend in water and add 1.56 ml of boron trifluoride/ether complex.
かくはん還流下に無水安息香酸2.89を含むアセトニ
トリル10m1溶液を10分間を要して滴下する。滴下
後5分間還流したのち溶媒を減圧下に留去する。While stirring and refluxing, a solution of 10 ml of acetonitrile containing 2.89 g of benzoic anhydride was added dropwise over 10 minutes. After the dropwise addition, the mixture was refluxed for 5 minutes, and then the solvent was distilled off under reduced pressure.
得られる残査にエーテルとエタノールとを少量加えて結
晶化し、口取することにより、02,2′−アンヒトロ
ー1−(3/,51−ジ一0−ベンゾイル一β−D−ア
ラビノフラノシノ(ハ)シトシン・HBF4塩1.79
を得る。収率79%実施例 4〜12実施例1〜3に準
じて反応することにより下記第1表に示す化合物を合成
することが出来る。The resulting residue is crystallized by adding a small amount of ether and ethanol, and taken by mouth to obtain 02,2'-anthro-1-(3/,51-di-10-benzoyl-β-D-arabinofuranosino). (c) Cytosine/HBF4 salt 1.79
get. Yield: 79% Examples 4 to 12 Compounds shown in Table 1 below can be synthesized by reacting in accordance with Examples 1 to 3.
Claims (1)
下に反応させることを特徴とするO^2,2′−アンヒ
ドロ−1−(3′,5′−ジ−O−アシル−β−D−ア
ラビノフラノシル)シトシン塩類の製法。1 O^2,2'-anhydro-1-(3',5'-di-O-acyl-β-), which is characterized by reacting cytidine and an organic acid anhydride in the presence of boron trifluoride. Method for producing D-arabinofuranosyl) cytosine salts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50102269A JPS5927359B2 (en) | 1975-08-22 | 1975-08-22 | Production method of cytidine derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50102269A JPS5927359B2 (en) | 1975-08-22 | 1975-08-22 | Production method of cytidine derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5225782A JPS5225782A (en) | 1977-02-25 |
| JPS5927359B2 true JPS5927359B2 (en) | 1984-07-05 |
Family
ID=14322865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50102269A Expired JPS5927359B2 (en) | 1975-08-22 | 1975-08-22 | Production method of cytidine derivatives |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5927359B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5446651U (en) * | 1977-09-08 | 1979-03-31 | ||
| JPS63192264U (en) * | 1987-05-29 | 1988-12-12 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4844267A (en) * | 1971-06-03 | 1973-06-26 | ||
| JPS5136758B2 (en) * | 1971-12-14 | 1976-10-12 | ||
| JPS5229757B2 (en) * | 1973-06-13 | 1977-08-03 | ||
| JPS5344477B2 (en) * | 1973-07-27 | 1978-11-29 |
-
1975
- 1975-08-22 JP JP50102269A patent/JPS5927359B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5225782A (en) | 1977-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS597719B2 (en) | Production method of cytidine derivatives | |
| JPS5927359B2 (en) | Production method of cytidine derivatives | |
| BE779775A (en) | DERIVATIVES OF UREA, METHOD FOR PREPARING THEM AND THEIR APPLICATIONS | |
| JP2002322122A (en) | Method for producing carboxylic ester, and its 'onium' salt and salt mixture | |
| JPS61243042A (en) | Manufacture of acylbiphenyl | |
| JPS5934720B2 (en) | Shichijin Yuudou Taino Seihou | |
| JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
| JP2540295B2 (en) | Ascorbic acid derivative | |
| JP3059007B2 (en) | Method for producing 1- (2-carboxyphenyl) indazole derivative | |
| JPS5931509B2 (en) | Method for producing 3-hydroxy-3-methylphthalide or its nuclear substituted product | |
| JP3823385B2 (en) | Process for producing 2,4,5-trifluoro-3-iodobenzoic acid and esters thereof | |
| JPS6160673A (en) | Preparation of guanidinothiazole derivative | |
| SU427004A1 (en) | METHOD FOR OBTAINING ALKYL DERIVATIVES 2-METHYL FURANE | |
| JPH0262886A (en) | Optically active ferrocenylphosphine and production thereof | |
| JPS5838268A (en) | Preparation of uracil | |
| JPH0340024B2 (en) | ||
| JPH01100147A (en) | Optically active malonic acid ester derivative | |
| PT85256B (en) | PROCESS FOR THE PREPARATION OF 1- (3-BROMO- (2S) -METHYLPROPIONYL) -PYROLIDINE- (2S) -CARBOXYLIC ACID | |
| JPH01294661A (en) | Production of 4-acetoxyazetidinone derivative | |
| JPS63233980A (en) | Production of 2-acylfuran derivative | |
| HU184948B (en) | Process for preparing 5-substituted 4-oxo-pgi down 1 derivatives | |
| JPS6247180B2 (en) | ||
| JPS60105645A (en) | Production of arylsuccinic acid ester | |
| JPS61183285A (en) | Vinylimidazole derivative and salt thereof | |
| JP2007051128A (en) | Method for producing aniline having aralkyloxy or heteroaralkyloxy group |